ES2072471T3 - Nuevas 4-quinolil-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. - Google Patents

Nuevas 4-quinolil-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.

Info

Publication number
ES2072471T3
ES2072471T3 ES91104723T ES91104723T ES2072471T3 ES 2072471 T3 ES2072471 T3 ES 2072471T3 ES 91104723 T ES91104723 T ES 91104723T ES 91104723 T ES91104723 T ES 91104723T ES 2072471 T3 ES2072471 T3 ES 2072471T3
Authority
ES
Spain
Prior art keywords
axy
halogen
chain
formula
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91104723T
Other languages
English (en)
Inventor
Jurgen D I Stoltefuss
Horst Dr Boshagen
Siegfried Dr Goldmann
Alexander Dr Straub
Rainer Prof Dr Gross
Joachim Dr Hutter
Siegbert Dr Hebisch
Martin Dr Bechem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2072471T3 publication Critical patent/ES2072471T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPUESTOS CON FORMULA GENERAL (I) EN LA QUE R ELEVADO 1 Y R ELEVADO 5 SON IGUALES O DISTINTOS Y REPRESENTAN UN ALQUILO DE CADENA LINEAL O RAMIFICADA CON HASTA 8 ATOMOS DE C, R (AL CUADRADO) ES NITRO O CIANO O R ELEVADO 1 Y R (AL CUADRADO) FORMAN CONJUNTAMENTE UN ANILLO LACTONA CON FORMULA R ELEVADO 3 ES UN RESTO CON FORMULA EN LAS QUE R ELEVADO 6 ES HIDROGENO, HALOGENO O ALQUILO O ALCOXI DE CADENA LINEAL O RAMIFICADA CON HASTA 8 ATOMOS DE C CADA UNO, R ELEVADO 7 ES ARILO, EVENTUALMENTE SUSTITUIDO, CON 6 A 10 ATOMOS DE C O TIENILO O PIRIDILO, SUSTITUIDOS EVENTUALMENTE CON HALOGENO, R ELEVADO 4 ES HIDROGENO O ALQUILO, ALQUENILO, ALCADIENILO O ALQUINILO DE CADENA LINEAL O RAMIFICADA CADA UNO HASTA CON 10 ATOMOS DE C, QUE ESTAN SUSTITUIDOS EVENTUALMENTE HASTA DOS VECES DE FORMA IGUAL O DISTINTA POR HALOGENO, HIDROXI, CARBOXI, CIANO, NITRO, FENOXI O POR ALQUILTIO, ALCOXI, ALCOXICARBONILO, ACILO O ACILOXI DE CADENA LINEAL O RAMIFICADA CADA UNO HASTA CON 8 ATOMOS DE C O POR FENOXI O FENILO, AL MISMO TIEMPO, QUE ESTOS ULTIMOS PUEDEN ESTAR SUSTITUIDOS A SU VEZ HASTA DOS VECES DE FORMA IGUAL O DISTINTA POR HALOGENO O POR ALQUILO O ALCOXI DE CADENA LINEAL O RAMIFICADA CADA UNO HASTA CON 6 ATOMOS DE C. PROCEDIMIENTO PARA SU FABRICACION Y SU UTILIZACION EN MEDICAMENTOS, EN ESPECIAL EN PRODUCTOS CON ACCION INOTROPA POSITIVA.
ES91104723T 1990-04-06 1991-03-26 Nuevas 4-quinolil-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. Expired - Lifetime ES2072471T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011105A DE4011105A1 (de) 1990-04-06 1990-04-06 Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ES2072471T3 true ES2072471T3 (es) 1995-07-16

Family

ID=6403870

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91104723T Expired - Lifetime ES2072471T3 (es) 1990-04-06 1991-03-26 Nuevas 4-quinolil-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.

Country Status (18)

Country Link
US (1) US5100900A (es)
EP (1) EP0452712B1 (es)
JP (1) JPH04234873A (es)
KR (1) KR910018385A (es)
AT (1) ATE121398T1 (es)
AU (1) AU640217B2 (es)
CA (1) CA2039684A1 (es)
DE (2) DE4011105A1 (es)
DK (1) DK0452712T3 (es)
ES (1) ES2072471T3 (es)
FI (1) FI911615A7 (es)
GR (1) GR3015904T3 (es)
HU (1) HU208006B (es)
IE (1) IE66685B1 (es)
IL (3) IL97753A (es)
NZ (1) NZ237656A (es)
PT (1) PT97252B (es)
ZA (1) ZA912531B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4118707A1 (de) * 1991-06-07 1992-12-10 Bayer Ag Pharmazeutische verwendung von 3-formyl-1,4-dihydropyridinen, neue verbindungen und verfahren zu ihrer herstellung
DE4134760A1 (de) * 1991-10-22 1993-07-08 Bayer Ag Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4202526A1 (de) * 1992-01-30 1993-08-05 Bayer Ag Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4233601A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-substituierte Chinolin-5-carbonsäuren
DE4313690A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4321030A1 (de) * 1993-06-24 1995-01-05 Bayer Ag 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel
DE4426373A1 (de) * 1994-07-26 1996-02-01 Bayer Ag 3-Substituierte Chinolin-5-carbonsäurederivate und Verfahren zu ihrer Herstellung
DE4426374A1 (de) * 1994-07-26 1996-02-01 Bayer Ag 4-Amino-3-hydroxy-phthalimidin, sowie ein Verfahren zu seiner Herstellung
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
JP5564045B2 (ja) * 2008-09-02 2014-07-30 ノバルティス アーゲー 二環式キナーゼ阻害剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
US2400500A (en) * 1944-02-04 1946-05-21 Goodrich Co B F Dihydroquinoline condensation product
GB582254A (en) * 1944-05-15 1946-11-11 Burroughs Wellcome Co Quinoline substituted dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4049662A (en) * 1972-03-06 1977-09-20 Bayer Aktiengesellschaft 4-Quinoline and isoquinoline substituted 2,6-diamino-1,4-dihydropyridine derivatives
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3943140A (en) * 1972-09-30 1976-03-09 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-1,4-dihydropyridine derivatives
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4483985A (en) * 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
DE3311003A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinlactone, mehrere verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3311005A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
ZA912531B (en) 1992-01-29
FI911615L (fi) 1991-10-07
FI911615A0 (fi) 1991-04-04
DE4011105A1 (de) 1991-10-10
AU7414591A (en) 1991-10-10
EP0452712A1 (de) 1991-10-23
IE911143A1 (en) 1991-10-09
EP0452712B1 (de) 1995-04-19
PT97252B (pt) 1998-07-31
IL97753A (en) 1995-01-24
US5100900A (en) 1992-03-31
PT97252A (pt) 1992-01-31
GR3015904T3 (en) 1995-07-31
CA2039684A1 (en) 1991-10-07
KR910018385A (ko) 1991-11-30
ATE121398T1 (de) 1995-05-15
IL97753A0 (en) 1992-06-21
HU911121D0 (en) 1991-10-28
IL110792A0 (en) 1994-11-11
IE66685B1 (en) 1996-01-24
IL110792A (en) 1995-06-29
DE59105219D1 (de) 1995-05-24
DK0452712T3 (da) 1995-08-28
HUT58312A (en) 1992-02-28
HU208006B (en) 1993-07-28
JPH04234873A (ja) 1992-08-24
FI911615A7 (fi) 1991-10-07
AU640217B2 (en) 1993-08-19
NZ237656A (en) 1993-08-26

Similar Documents

Publication Publication Date Title
ES2053864T3 (es) Derivados de acido 4-(quinolin-2-il-metoxi)fenil-acetico substituido.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
DK571677A (da) I 2stillingen substituerede 1,4-dihydropyridinderivater fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
IT8920170A0 (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
ES2192853T3 (es) Compuestos ciclicos utiles en el tratamiento de la dislipidemia, aterosclerosis y diabetes, composiciones farmaceuticas y proceso de preparacion.
MX164399B (es) Composiciones generadoras de gas que contienen sales de acido 5-nitrobarbiturico,sales de acido nitroorotico o 5-nitrouracilo
IT7825237A0 (it) Derivati di acidi chinolon-carbossilici come battericidi.
IT7827557A0 (it) Composti ad azione analgesica comprendenti derivati di azacicloalcani.
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ES2126684T3 (es) Utilizacion de derivados de acidos carboxilicos aromaticos para la preparacion de medicamentos.
ES2099362T3 (es) Derivados de octahidrofenantreno.
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
ES2073393T3 (es) Derivados de acidos 2,4- y 2,5-dicarboxilicos, procedimiento para su preparacion, utilizacion de los mismos asi como medicamentos a base de estos compuestos.
IT7827493A0 (it) Derivati di acidi amidinosolfonici, processo per la loro preparazione e composizioni farmaceutiche che contengono questi derivati.
IT1190401B (it) Derivati di vitamina d,composizioni farmaceutiche che li contengono e loro precursori
IT1103117B (it) Derivati della piperidina e procedimento per la loro preparazione e composizioni medicinali che le comprendono
ES8308549A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
IT7922150A0 (it) Derivati dell'isochinolina, loro preparazione, e composizioni farmaceutiche che li contengono.
IT1038688B (it) 1.2.4 triazolil i derivati processo per la loro preparazione loro impiego come sdiancanti ottici
GT198900080A (es) Procedimiento de preparar una composicion farmaceutica a base de trimebutina
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
ES2036583T3 (es) Iminooxazolidinas, procedimiento de preparacion y metodo de uso.
ES2085922T3 (es) 3-tia- o 3-oxa-alquil-flavonas sustituidas, procedimiento para su preparacion, empleo de las mismas, medicamentos a base de estos compuestos, asi como productos intermedios.
IT1096218B (it) Derivati dell'idrossi-4 tiazolidintione-2,loro preparazione e composizioni che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 452712

Country of ref document: ES